BioLineRx Ltd. Sales And Marketing Expense
BioLineRx Ltd. (BLRX) reported Sales And Marketing Expense of $0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SalesAndMarketingExpense · last filed 2026-03-23
- BioLineRx Ltd. sales and marketing expense for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- BioLineRx Ltd. sales and marketing expense for the quarter ending 2024-06-30 was $6.42M, a 14.47% increase year-over-year.
- BioLineRx Ltd. sales and marketing expense for the quarter ending 2023-06-30 was $5.60M, a 383.94% increase year-over-year.
- BioLineRx Ltd. sales and marketing expense for the quarter ending 2022-06-30 was $1.16M, a 250.91% increase year-over-year.
| Period end | Sales And Marketing Expense 3 month | Sales And Marketing Expense 6 month | Sales And Marketing Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-03-23 | ||
| 2025-06-30 | $0.00 6-K · filed 2025-08-14 | $0.00 6-K · filed 2025-08-14 | |
| 2024-12-31 | $23.61M 20-F · filed 2026-03-23 | ||
| 2024-06-30 | $6.42M 6-K · filed 2025-08-14 | $12.76M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $25.27M 20-F · filed 2026-03-23 | ||
| 2023-06-30 | $5.60M 6-K · filed 2024-08-15 | $9.48M 6-K · filed 2024-08-15 | |
| 2022-12-31 | $6.46M 20-F · filed 2025-03-31 | ||
| 2022-06-30 | $1.16M 6-K · filed 2023-08-30 | $1.79M 6-K · filed 2023-08-30 | |
| 2021-12-31 | $1.00M 20-F · filed 2024-03-26 | ||
| 2021-06-30 | $330.00K 6-K · filed 2022-08-16 | $484.00K 6-K · filed 2022-08-16 | |
| 2020-12-31 | $840.00K 20-F · filed 2023-03-22 | ||
| 2020-06-30 | $182.00K 6-K · filed 2021-08-18 | $357.00K 6-K · filed 2021-08-18 | |
| 2019-12-31 | $857.00K 20-F · filed 2022-03-16 | ||
| 2019-06-30 | $226.00K 6-K · filed 2020-08-06 | $482.00K 6-K · filed 2020-08-06 | |
| 2018-12-31 | $1.36M 20-F · filed 2021-02-23 | ||
| 2018-06-30 | $360.00K 6-K · filed 2019-08-06 | $844.00K 6-K · filed 2019-08-06 | |
| 2017-12-31 | $1.69M 20-F · filed 2020-03-12 | ||
| 2017-06-30 | $288.00K 6-K · filed 2018-08-13 | $969.00K 6-K · filed 2018-08-13 | |
| 2016-12-31 | $1.35M 20-F · filed 2019-03-28 | ||
| 2015-12-31 | $1.00M 20-F · filed 2018-03-06 |